Results
eNauka >
Rezultati >
Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study
| Naziv: | Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study | Autori  : | O'Shaughnessy, Joyce; ...; Cvetanovic, Ana S; ...; Stamatovic, Ljiljana | Godina: | 2021 | Publikacija: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 152 str. 223-232 | DOI: | 10.1016/j.ejca.2021.03.047 | WoS-ID: | 000678059500021 | Scopus-ID: | 2-s2.0-85107914072 | URI: | https://zenodo.org/record/5196150 https://enauka.gov.rs/handle/123456789/935206 |
Projekat: | F. Hoffmann-La Roche Ltd.Hoffmann-La Roche | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.